Nazotason Nasal Spray (Mometasone Furoate)
Mometasone Furoate 0.5mg
Suspension · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
MFDS item code 201310372 · Notified 2013.11.29 · Insurance code 657306171
Prevention and alleviation of symptoms related to allergic rhinitis and sinusitis (including polyps).
This medication is used to relieve the symptoms of seasonal allergic rhinitis or perennial rhinitis in adults and children aged 2 years and older. Additionally, it is effective for the treatment of nasal polyps in adults over 18 years of age and is utilized for the treatment of acute sinusitis without severe bacterial infection in adults and adolescents aged 12 and older. It can be taken prophylactically before symptoms appear, starting 2-4 weeks prior to allergen exposure for enhanced effectiveness. This medication helps improve and treat symptoms related to allergies and rhinitis.
Allergic Rhinitis: Generally, spray twice in each nostril once daily (total daily dose of 0.2 mg). For maintenance, adjust to one spray in each nostril as symptoms improve (total daily dose of 0.1 mg). Maximum permitted is four sprays in each nostril once daily (total daily dose of 0.4 mg). Nasal Polyps: Generally, spray twice in each nostril once daily (total daily dose of 0.2 mg).
Children aged 2 to 11 years: Generally, spray once in each nostril once daily (total daily dose of 0.1 mg).
This medication should not be used in certain patients. For instance, patients who have had an allergy or hypersensitivity reaction to this medication or its components, patients with untreated infections in the nasal mucosa, patients who have recently had nasal surgery or have wounds in the nose should avoid using this medication. Also, it should not be administered to children under 2 years of age. Patients who need to exercise caution while using this medication include those with active tuberculosis or systemic infections, those with herpes simplex in the eyes, patients who experience recurrent nosebleeds, those at risk of exposure to chickenpox or measles, patients with specific nasal diseases, and women who are pregnant or breastfeeding. While using this medication, a variety of side effects may occur including headaches, viral infections, pharyngitis, nosebleeds, cough, etc., and adverse reactions may develop in some patients to the extent that discontinuing use of the medication is necessary. In rare cases, serious allergic reactions such as anaphylaxis may occur, so immediate consultation with medical personnel is required if abnormal symptoms appear. Long-term high-dose administration may lead to systemic side effects, therefore caution is necessary, and if symptoms of nasal infection appear, discontinuation or appropriate treatment may be needed. Moreover, changes in vision or ocular issues such as glaucoma and cataracts may occur, so regular eye examinations are recommended. This medication may affect growth, hence pediatric patients should have their growth monitored regularly, and elderly patients should be administered with caution considering the decline in bodily function. Attention should be paid to drug interactions, especially when used in combination with specific antifungals or antibiotics since the risk of side effects may increase; therefore, consultation with healthcare providers is necessary. Pregnant or breastfeeding women should carefully evaluate the potential risks and benefits of using this medication, and newborns should be closely monitored for adrenal function abnormalities. Before use, the container should be shaken well and test sprays should be performed to ensure proper uniform spraying. After use, it should be stored out of reach of children. Additionally, this medication is intended for nasal spray only and care should be taken not to spray directly into the eyes or the nasal septum.
Hives, severe swelling, chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin shedding, pain in the mucous membranes of the mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory anomalies with cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headaches, lightning headaches, seizures, confusion, visual disturbances, paralysis, significantly reduced urine volume.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity, so it must be stored in a sealed container. The recommended storage temperature is room temperature between 2 to 25 degrees. Proper storage helps maintain the medication's effectiveness and safety over time.
An opaque suspension that is white or nearly white, contained in a device that dispenses a defined amount per spray.
18mL (140 sprays)/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Mometasone Furoate 0.5mg
Suspension · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Mometasone Furoate Monohydrate 0.517mg
Suspension · Prescription medication
Korea Organon Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Korea Organon Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Mometasone Furoate 1mg
Ointment · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Bionex Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Taegeuk Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.